Axonics Inc. (NASDAQ:AXNX) rose 1.5% in after hours trading after a jury voted in is favor in a patent dispute with Medtronic ...

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

The analysis comes as regulators investigate how the FDA authorizes medical devices and handles safety recalls.

Medtronic's latest Deep Brain Stimulation device allows Bruce Lunde to control his tremors remotely, with a cell phone, and ...

"Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership" was originally created and published by ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

An FDA-qualified accelerated testing tool verifies the performance of new materials at long human implant times.